Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance

Journal of Medicinal Chemistry

Volumn 57, Issue 7, 2014, Pages 2843-2844

  Liu, Liu ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90 INHIBITOR; LEAD; ORGANIC SOLVENT;

ARTICLE; DISSOCIATION; DRUG SCREENING; DRUG SYNTHESIS; MASS SPECTROMETRY; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE;

BIOSENSING TECHNIQUES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; PHARMACEUTICAL PREPARATIONS; SMALL MOLECULE LIBRARIES; SURFACE PLASMON RESONANCE;

EID: 84898444292     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm5003815     Document Type: Article

References (13)

1. Paul, S. M.; Mytelka, D. S.; Dunwiddie, C. T.; Persinger, C. C.; Munos, B. H.; Lindborg, S. R.; Schacht, A. L. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discovery 2010, 9, 203-214
2. Adams, C. P.; Brantner, V. V. Spending on new drug development Health Econ. 2010, 19, 130-141
3. Bryan, M. C.; Hein, C. D.; Gao, H.; Xia, X.; Eastwood, H.; Bruenner, B. A.; Louie, S. W.; Doherty, E. M. Disubstituted 1-aryl-4-aminopiperidine library synthesis using computational drug design and high-throughput batch and flow technologies ACS Comb. Sci. 2013, 15, 503-511
4. Czechtizky, W.; Dedio, J.; Desai, B.; Dixon, K.; Farrant, E.; Feng, Q.; Morgan, T.; Parry, D. M.; Ramjee, M. K.; Selway, C. N.; Schmidt, T.; Tarver, G. J.; Wright, A. G. Integrated synthesis and testing of substituted xanthine based DPP4 inhibitors: application to drug discovery ACS Med. Chem. Lett. 2013, 4, 768-772
5. Desai, B.; Dixon, K.; Farrant, E.; Feng, Q.; Gibson, K. R.; van Hoorn, W. P.; Mills, J.; Morgan, T.; Parry, D. M.; Ramjee, M. K.; Selway, C. N.; Tarver, G. J.; Whitlock, G.; Wright, A. G. Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform J. Med. Chem. 2013, 56, 3033-3047
6. Guetzoyan, L.; Nikbin, N.; Baxendale, I. R.; Ley, S. V. Flow chemistry synthesis of zolpidem, alpidem and other GABAA agonists and their biological evaluation through the use of in-line frontal affinity chromatography Chem. Sci. 2013, 4, 764-769
7. Browne, D. L.; Wright, S.; Deadman, B. J.; Dunnage, S.; Baxendale, I. R.; Turner, R. M.; Ley, S. V. Continuous flow reaction monitoring using an on-line miniature mass spectrometer Rapid Commun. Mass Spectrom. 2012, 26, 1999-2010
8. Murray, J. B.; Roughley, S. D.; Matassova, N.; Brough, P. A. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products. J. Med. Chem. 2014, DOI: 10.1021/jm401848a.
9. Carr, R. A.; Congreve, M.; Murray, C. W.; Rees, D. C. Fragment-based lead discovery: leads by design Drug Discovery Today 2005, 10, 987-992
10. Congreve, M.; Murray, C. W.; Carr, R.; Rees, D. C. Fragment-based lead discovery Annu. Rep. Med. Chem. 2007, 42, 431-448
11. Tanaka, D. Fragment-based drug discovery: concept and aim Yakugaku Zasshi 2010, 130, 315-23
12. Holdgate, G. A.; Gill, A. L. Kinetic efficiency: the missing metric for enhancing compound quality? Drug Discovery Today 2011, 16, 910-913
13. Bai, F. Free energy landscape for the binding process of huperzine A to acetylcholinesterase Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 4273-4278